Modular Medical, Inc. - common stock (MODD)
1.2000
-0.0100 (-0.83%)
Modular Medical Inc is a medical technology company focused on developing innovative solutions for diabetes management, particularly through its advanced insulin delivery systems
The company aims to enhance the quality of life for individuals living with diabetes by creating user-friendly, reliable, and effective devices that streamline the insulin administration process. By harnessing cutting-edge technology, Modular Medical seeks to empower patients and healthcare providers with improved tools for better diabetes control and overall health outcomes.
![](https://cdn.benzinga.com/files/images/story/2024/09/05/earnings_0.jpeg?width=1200&height=800&fit=crop)
Modular Medical shares are trading higher Thursday after the company announced it has received U. S. Food and Drug Administration (FDA) clearance to market and sell its MODD1 pump in the United States.
Via Benzinga · September 5, 2024
![](https://cdn.benzinga.com/files/images/story/2024/09/05/movers-image.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · September 5, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
MODD stock results show that Modular Medical beat analyst estimates for earnings per share the first quarter of 2025.
Via InvestorPlace · August 14, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
MODD stock results show that Modular Medical beat analyst estimates for earnings per share the fourth quarter of 2024.
Via InvestorPlace · June 28, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · May 13, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · March 27, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · February 19, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · February 16, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · February 15, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · February 13, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · January 16, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · January 9, 2024
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · December 7, 2023
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · December 7, 2023
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · November 24, 2023
![](https://cdn.benzinga.com/files/images/story/2023/11/02/image30.jpeg?width=1200&height=800&fit=crop)
The Dow Jones closed higher by over 200 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Via Benzinga · November 2, 2023
![](https://cdn.benzinga.com/files/images/story/2023/10/19/image20.jpeg?width=1200&height=800&fit=crop)
The Dow Jones closed lower by over 300 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Via Benzinga · October 19, 2023
![](https://cdn.benzinga.com/files/images/story/2023/10/31/jetblue_airways_-_logo.jpg?width=1200&height=800&fit=crop)
Gainers SciSparc Ltd. (NASDAQSPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for Combination of Opioids and N-Acylethanolamines for pain treatment.
Via Benzinga · October 31, 2023
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · October 16, 2023
![](https://cdn.benzinga.com/files/images/story/2023/10/16/image19.jpg?width=1200&height=800&fit=crop)
Gainers MingZhu Logistics Holdings Limited (NASDAQYGMZ) shares gained 64% to $0.7798 after gaining more than 10% on Friday.
Via Benzinga · October 16, 2023
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · September 26, 2023
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · September 12, 2023
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · August 24, 2023
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga · August 24, 2023
![](https://cdn.benzinga.com/files/images/story/2023/08/23/amc_-_logo.jpg?width=1200&height=800&fit=crop)
Gainers BioNexus Gene Lab Corp. (NASDAQBGLC) shares gained 48.5% to $2.05 in pre-market trading after jumping 30% on Tuesday.
Via Benzinga · August 23, 2023